Navigation Links
CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Date:8/22/2007

Side Effect Profile and Tolerability of Regadenoson Myocardial Perfusion Scintigraphy in Women; Poster, Tuesday, September 4, 2:00 - 6:00 p.m. CEST

Superior Safety Profile of Regadenoson Versus Adenosine in Patients with Chronic Obstructive Pulmonary Disease Undergoing Radionuclide Myocardial Perfusion Imaging; Poster, Tuesday, September 4, 2:00 - 6:00 p.m. CEST

In addition, on Tuesday, September 4, CV Therapeutics is sponsoring an EBAC (European Board for Accreditation in Cardiology) educational program, Targeting Myocardial Ischaemia-Future Opportunities for Improved Outcomes, chaired by Dr. Phillip Poole-Wilson of the United Kingdom and Dr. Eugene Braunwald of the United States. On Monday, September 3, CV Therapeutics is sponsoring a FOCUS Cardiology Practice Session, Chronic Stable Angina Management.

Additional information regarding the ESC Congress 2007 can be accessed at http://www.escardio.org

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved product, Ranexa(R) (ranolazine extended-release tablets), is indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

CV Therapeutics' clinical and preclinical drug development candidates and programs include regadenoson, which is being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies, and CVT- 6883, which is being developed as a potential treatment for cardiopulmonary diseases. Regadenoson and CVT-6883 have not been determined by any regulatory authorities to be safe or e
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... 2015  Building on the momentum of the first quarter ... medical alert systems, has announced aggressive plans to expand its ... Managed Care business models. The first quarter addition ... Tennessee and Louisiana ... to span statewide coverage in each state. This brings the ...
(Date:3/30/2015)... -- A team of Chinese and US scientists has ... that plays a critical role in thrombosis, or blood ... features, which challenge the conventional concepts of drug action ... door for future drug discovery. In a ... the researchers at Shanghai Institute of Materia Medica ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6
... SEATTLE, June 18 On Wednesday, June 18, 2008,at ... Cell Therapeutics, Inc.,s (CTI) (Nasdaq: CTIC ; MTA) ... with Bayer Schering Pharma for,access to Phase III Zevalin(R) ... Wednesday, June 18 8:30 a.m. Eastern/2:30 p.m. Central ...
... Data Highlights the Need for Testosterone Screening in At-Risk ... ... New data from a 12-month,international, multi-center study showed that treatment for ... insulin sensitivity and sexual function among,hypogonadal men with Type 2 diabetes ...
Cached Medicine Technology:Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome 2Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome 3
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... independent freestanding emergency rooms in the United States, announced ... April. , “I am pleased to announce that ... Worth metroplex in Haslet,” said Dr. James M. Muzzarelli, ... , First Choice Emergency Room is revolutionizing the delivery ...
(Date:3/31/2015)... Dr. Hendler’s Vitamin Mints is a ... With a recent debut on Food Fortunes , Food ... Mint Company embraces Gonzo style publicity and pulls out all ... , The Vitamin Mint -- created by the late ... Supplements, (a.k.a. the bible of supplements) and other great works ...
(Date:3/31/2015)... March 31, 2015 The legendary rock and ... October 2 in North America, and dates for Van Halen ... group will perform many great hits during upcoming shows, and ... 30 on Hollywood Boulevard that will air on Jimmy Kimmel ... in the U.S. featuring David Lee Roth. , Visit ...
(Date:3/30/2015)... March 31, 2015 Wireless Analytics, ... services, has been announced as one of the Boston ... the fastest-growing private companies in Massachusetts. The list ... fastest revenue growth from 2011 through 2014. 2015 ... Business Journal has recognized Wireless Analytics’s revenue growth. ...
(Date:3/30/2015)... March 31, 2015 Software and ... FDA’s Position and Best Practices for Compliance, **Presented ... Bethesda, MD, http://www.fdanews.com/CybersecurityMDWorkshop , This workshop ... — has been specifically designed to provide attendees ... effectively assure medical device software safety. , In ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:What Do Mints, a World Renowned UCSD Biochemist, Vitamins and a Zany Musician Have in Common? 2Health News:Van Halen Presale Tickets: QueenBeeTickets.com Kicks Off Van Halen Ticket Sales with Reduced Prices on Seats for the 2015 Concert Tour During This Week's Presales 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 2Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 3Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 4
... link between neurons, blood vessels, researchers say , , THURSDAY, ... astrocytes play a key role in allowing experts to ... brain scans, according to a report by researchers at ... previously thought of as minor players in brain activity, ...
... We Give is the title of a new book that will ... share what they have to improve their lives and the lives ... B. Gunderman, M.D., Ph.D. guides readers through reflection on and discussion ... book, Dr. Gunderman expands on the adage, "We make a living ...
... -,regardless of whether they are enrolled in ... the Medicare Advantage program to fund the,Medicare ... Medicare Advantage will,have a negative effect on ... Point Presentation: http://www.ahip.org/content/default.aspx?docid=23669 , Memo ...
... Record of Program, Head Start Officials,Bracing for Worst Under ... New President, Congress to Address Long-Term $1 Billion Budget,Crisis., ... billion cut in funding since 2002, cash-strapped Head Start ... to seek up to 14,000 child,enrollment cuts now that ...
... odds of this cluster of heart risk factors, experts say ... developing metabolic syndrome -- a group of factors linked to ... common gene variations, researchers say. , But one additional variant ... , People with metabolic syndrome run four times the risk ...
... Federal Reserve chairman Ben Bernanke,s,comments this week that improving ... of the biggest challenges facing the nation, plus a ... nearly 10 percent this,year, lend strong support to the ... according to U.S. Preventive Medicine, the leader,in disease prevention., ...
Cached Medicine News:Health News:Star-Shaped Brain Cells Make Scans Possible 2Health News:Seniors Oppose Cutting Medicare Advantage to Fund Physician Payment Fix 2Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 2Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 3Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 4Health News:Head Start Leaders Have High Hopes for New President and Congress, But Budget 'Double Whammy' Expected to Force Cuts of Up to 14,000 Child Slots Nationwide 5Health News:Metabolic Syndrome May Be in the Genes 2Health News:U.S. Preventive Medicine Views Bernanke's Comments as Strong Support for Prevention and Wellness Programs 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: